Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
For the nine months, sales was USD 852.96 million compared to USD 835.38 million a year ago. Net income was USD 127.52 million compared to USD 209.78 million a year ago. Basic earnings per share from continuing operations was USD 0.81 compared to USD 1.34 a year ago. Diluted earnings per share from continuing operations was USD 0.79 compared to USD 1.3 a year ago.